Yüklüyor......
Ritonavir acts synergistically with panobinostat to enhance histone acetylation and inhibit renal cancer growth
There is currently no curative treatment for advanced renal cancer. Enhancing histone acetylation is a promising epigenetic-based therapy for cancer; however, in solid tumors, the efficacy of histone deacetylase (HDAC) inhibitors alone is limited. The human immunodeficiency virus protease inhibitor...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
D.A. Spandidos
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4179797/ https://ncbi.nlm.nih.gov/pubmed/25279191 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2014.349 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|